NASDAQ:ADXN

Addex Therapeutics Short Interest Ratio and Short Volume

$9.30
-0.31 (-3.23 %)
(As of 07/23/2021 04:51 PM ET)
Add
Compare
Today's Range
$9.30
$9.78
50-Day Range
$9.09
$11.25
52-Week Range
$8.01
$37.52
Volume1,990 shs
Average Volume51,646 shs
Market Capitalization$76.37 million
P/E RatioN/A
Dividend YieldN/A
Beta2.17

Addex Therapeutics (NASDAQ:ADXN) Short Interest Data

Current Short Volume200 shares
Previous Short Volume5,000 shares
Change Vs. Previous Month-96.00%
Dollar Volume Sold Short$1,912.00
Short Interest Ratio / Days to Cover0.0
Last Record DateJune, 30 2021
Outstanding Shares8,212,000 shares
Percentage of Shares Shorted0.00%
Today's Trading Volume1,990 shares
Average Trading Volume51,646 shares
Today's Volume Vs. Average-96.15%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Addex Therapeutics ?

Sign up to receive the latest short interest report for Addex Therapeutics and its competitors with MarketBeat's FREE newsletter.

Addex Therapeutics (NASDAQ:ADXN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2021200 shares $1,912.00 -96.0%N/A0 $9.56
6/15/20215,000 shares $55,000.00 +354.6%N/A0.7 $11.00
5/28/20211,100 shares $10,285.11 -73.2%N/A0.2 $9.35
5/14/20214,100 shares $37,064.00 -43.1%N/A0.4 $9.04
4/30/20217,200 shares $71,928.00 +200.0%N/A0.4 $9.99
4/15/20212,400 shares $25,128.00 +140.0%N/A0.1 $10.47
3/31/20211,000 shares $10,400.00 -47.4%N/A0 $10.40
3/15/20211,900 shares $20,501.00 -71.2%N/A0 $10.79
2/26/20216,600 shares $74,580.00 +57.1%N/A0.1 $11.30
2/12/20214,200 shares $47,880.00 -67.9%N/A0 $11.40
1/29/202113,100 shares $144,755.00 +1,090.9%N/A0.1 $11.05
1/15/20211,100 shares $11,814.00 No ChangeN/A0 $10.74

Addex Therapeutics (NASDAQ:ADXN) Short Interest FAQ

speech bubbles
speech bubbles











What is Addex Therapeutics' current short interest?

Short interest is the volume of Addex Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 200 shares of ADXN short. Learn More on Addex Therapeutics' current short interest.

Is Addex Therapeutics' short interest increasing or decreasing?

Addex Therapeutics saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 200 shares, a decrease of 96.0% from the previous total of 5,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Addex Therapeutics' short interest compare to its competitors?

0.00% of Addex Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Addex Therapeutics: MedAvail Holdings, Inc (1.68%), Fortress Biotech, Inc. (1.80%), Clearside Biomedical, Inc. (3.56%), Wave Life Sciences Ltd. (6.39%), MEI Pharma, Inc. (9.62%), Syros Pharmaceuticals, Inc. (11.38%), Verrica Pharmaceuticals Inc. (14.19%), CymaBay Therapeutics, Inc. (11.89%), 9 Meters Biopharma, Inc. (3.85%), and Taiwan Liposome Company, Ltd. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($8.32 billion), AstraZeneca PLC ($8.20 billion), Square, Inc. ($7.79 billion), Analog Devices, Inc. ($7.16 billion), S&P Global Inc. ($7.07 billion), Aon plc ($6.17 billion), Charter Communications, Inc. ($5.38 billion), Wayfair Inc. ($4.80 billion), AMC Entertainment Holdings, Inc. ($4.28 billion), and Snowflake Inc. ($3.19 billion). View all of the most shorted stocks.

What does it mean to sell short Addex Therapeutics stock?

Short selling ADXN is an investing strategy that aims to generate trading profit from Addex Therapeutics as its price is falling. Addex Therapeutics' stock is trading down $0.31 today. To short Addex Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Addex Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Addex Therapeutics?

A short squeeze for Addex Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADXN, which in turn drives the price of the stock up even further.

How often is Addex Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADXN, twice per month. The most recent reporting period available is June, 30 2021.



This page was last updated on 7/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.